Wheeler Penny Ann Acquires NRC Health Shares

Wheeler Penny Ann recently made a move in the stock market by purchasing 7,697 shares of NRC Health. This transaction took place on June 23, 2026, and was not part of a pre-arranged trading plan. As of Friday, shares of NRC Health, trading on the NasdaqGS under the ticker NRC, were priced at $20.43.

Other Institutional Activity in NRC Health

Several institutional investors have also been active in NRC Health. Vanguard Capital Management LLC opened a new position, acquiring 662,837 shares valued at approximately $11.25 million. Meanwhile, other large investors like BlackRock, Inc. and Morgan Stanley trimmed their holdings. BlackRock reduced its stake by 29,468 shares, bringing its total to 975,855 shares worth about $16.57 million. Similarly, Morgan Stanley decreased its position slightly by 1,829 shares, leaving it with 1,001,880 shares valued at $17.01 million.

NRC Health Stock Down 6.5%

NRC Health, with a market capitalization of $439.2 million, trades on the NasdaqGS under the ticker NRC. The company exhibits a P/E ratio of 49.97 and a forward P/E of 16.80, suggesting expectations of future earnings growth. The stock's 52-week range spans from $11.01 to $22.79, and its 50-day moving average is $18.40. NRC Health has a beta of 0.399, indicating lower volatility compared to the market.

Recent Earnings

In its latest financial results, NRC Health reported revenue of $138.64 million, reflecting a modest growth rate of 3.7%. The company's net margin stood at 6.5%, and it achieved a return on equity of 41.86%. Looking ahead, NRC Health is scheduled to announce its next earnings on July 27, 2026.

Dividend

NRC Health offers a dividend with an annual rate of $0.60, yielding 3.24%. The company's dividend payout ratio is notably high at 143.59%, which may indicate that it is paying out more in dividends than it earns in net income.

Insider Buying and Selling at NRC Health

In addition to Wheeler Penny Ann, several other insiders bought shares of NRC Health on June 23, 2026. These include Stephen Lockhart, Parul Bhandari, Donald Berwick, and John Nunnelly, each acquiring 7,697 shares. Earlier, on March 12, 2026, Jason Russell Rau, Executive Vice President, purchased 60,000 shares.

Analysts Set New Price Targets

On June 22, 2026, Citizens initiated coverage on NRC Health with a "buy" rating and set a price target of $23. This reflects optimism about the company's future prospects. The consensus among analysts is generally positive, with a mean price target that suggests potential upside.

About NRC Health

NRC Health, headquartered in Lincoln, Nebraska, provides analytics and insights to healthcare organizations across the United States. The company focuses on enhancing patient and employee experiences through various solutions, including market and patient experience, employee engagement, and consumer insights. Led by CEO Mr. Trent S. Green, NRC Health employs 357 people and offers a range of services from AI-driven analytics to governance solutions.

Bottom Line

Wheeler Penny Ann's recent purchase of NRC Health shares highlights ongoing insider confidence in the company. NRC Health's robust analytics services and its strategic position in the healthcare sector make it a company to watch. Remember, insider transactions and 13F filings are backward-looking and may not reflect current positions.